Cluster Headache Epidemiology Insight Report 2021-2030 - ResearchAndMarkets.com
Cluster Headache Epidemiology Insight Report 2021-2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Cluster Headache - Epidemiology Insight - 2030" report has been added to ResearchAndMarkets.com's offering.
This 'Cluster Headache (CH) - Epidemiology Forecast - 2030' report delivers an in-depth understanding of and historical and forecasted epidemiology of Cluster Headache in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Cluster Headache Epidemiology
The CH epidemiology division provides insights about the historical and current patient pool, along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends and assumptions undertaken.
Country-wise Cluster Headache Epidemiology
The epidemiology segment also provides the Cluster Headache epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
The total prevalent cases of Cluster Headache associated in 7MM countries were 877,859 in 2020.
- As per the estimates, the United States has the largest prevalent population of Cluster Headache.
- Among the EU5 countries, Germany had the highest prevalent cases of Cluster Headache, followed by France. On the other hand, Spain had the lowest prevalent cases, with 61,798 cases in 2020.
Key Topics Covered:
1 Key Insights
2 Report Introduction
3 Cluster Headache Epidemiology Overview at a Glance
3.1 Patient Share (%) Distribution of Cluster Headache in 2018
3.2 Patient Share (%) Distribution of Cluster Headache in 2030
4 Executive Summary of Cluster Headache
5 Disease Background and Overview
5.1 Introduction
5.2 Classification of Cluster Headache
5.3 Clinical Characteristics
5.4 Comorbidities associated with Cluster Headache
5.5 Cluster Headache versus Migraine
5.6 Risk Factors associated with Cluster Headache
5.7 Pathophysiology
5.1.1 Trigeminovascular System
5.1.2 Parasympathetic Activation
5.1.3 Hypothalamus Activation
5.8 Diagnosis
5.1.4 Differential Diagnosis
5.9 Treatment
6 Epidemiology and Patient Population
6.1 Key Findings
6.2 7MM Total Diagnosed Incident Population of Cluster Headache
6.3 Epidemiology of Cluster Headache
6.4 The United States
6.4.1 Prevalence of Cluster Headache in the United States
6.4.2 Diagnosed cases of Cluster Headache in the United States
6.4.3 Type-specific cases of Cluster Headache in the United States
6.4.4 Gender-specific cases of Cluster Headache in the United States
6.4.5 Age-specific cases of Cluster Headache in the United States
6.5 EU5
6.5.1 Germany
6.5.2 France
6.5.3 Italy
6.5.4 Spain
6.5.5 United Kingdom
6.6 Japan
7 KOL Views
8 Market Drivers
9 Market Barriers
10 SWOT Analysis
11 Unmet Needs
12 Market Access
13 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/na2koh
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
